Virus-like particles as vaccine adjuvants

Applied Biochemistry and Biotechnology - Part B Molecular Biotechnology

Volumn 19, Issue 2, 2001, Pages 169-177

  Gilbert, S C ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

CTL; Recombinant sub unit vaccine; Ty VLP; Virus like particle

Indexed keywords

ADJUVANT; VIRUS VACCINE;

ANIMAL EXPERIMENT; ARTICLE; CYTOTOXIC T LYMPHOCYTE; DRUG FORMULATION; IMMUNOGENICITY; MOUSE; NONHUMAN; SACCHAROMYCES CEREVISIAE; VIRUS PARTICLE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BASE SEQUENCE; CD8-POSITIVE T-LYMPHOCYTES; DNA PRIMERS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EPITOPES; EPITOPES, T-LYMPHOCYTE; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PLASMIDS; PLASMODIUM BERGHEI; SACCHAROMYCES CEREVISIAE; VACCINATION; VACCINES, SYNTHETIC; VIRAL VACCINES; VIRUSES;

EID: 0034783495     PISSN: 10736085     EISSN: None     Source Type: Journal    
DOI: 10.1385/MB:19:2:169     Document Type: Article

References (27)

1. Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara
2. Distribution of DNA vaccines determines their immunogenicity after intramuscular injection in mice
3. Hepatitis B virus small surface antigen particles are processed in a novel endosomal pathway for major histocompatibility complex class I-restriced epitope presentation
4. Priming of class I-restricted cytotoxic T lymphocytes by vaccination with recombinant protein antigens
5. Immunization with soluble hepatitis B virus sàzface protein elicits murine H-2 class I-restricted CD8+ cytotoxic T lymphocyte resonses in vivo
6. The effects of adjuvants on CTL induction by V3:Ty-virus-like-particles (V3-VLPs) in mice
7. Safety and immunogenicity of a candidate therapeutic vaccine, p24 virus-like aprticle, combined with zidovudine, in asymptomatic subjects
8. Oral immunisation with recombinant Norwalk virus-like particles induces a systemic and mucosal immune response in mice
9. Rotavirus virus-like particles administered mucosally induce protective immunity
10. Specific interactions between human integrin alpha v beta 3 and chimeric hepatitis B virus core particles bearing the receptor-binding epitope of foot-and-mouth disease virus
11. Plant-derived vaccine protects target animals against a viral disease
12. Malaria vaccines: Triumphs or tribulations?
13. A phase I safety and immunogenicity trial with the candidate malaria vaccine RTS,S/SBAS2 in semi-immune adults in The Gambia
14. Potent induction of focused Th1-type cellular and humoral immune responses by RTS,S/SBAS2, a recombinant plasmodium falciparum malaria vaccine
15. Long-term efficacy and immune responses following immunization with the RTS,S malaria vaccine
16. A new form of particulate single and multiple immunogen delivery system based on recombinant bluetongue virus-derived tubules
17. Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model
18. Production and purification of hybrid Ty-VLPs
19. A protein particle vaccine containing multiple malaria epitopes
20. Comparison of numerous delivery systems for the induction of cytotoxic T lymphocytes by immunization
21. Mucosal or targeted lymph node immunization of macaques with a particulate SIVp27 protein elicits virus-specific CTL in the genito-rectal mucosa and draining lymph notes
22. Induction of high-titer neutralizing antibodies, using hybrid human immunodeficiency virus V3-Ty virus-like particles in a clinically relevant adjuvant
23. Immunogenicity of the yeast recombinant p 17/p24:Ty virus-like particles (p24-VLP) in healthy volunteers
24. Immunization of human HIV-seronegative volunteers with recombinant p17/p24:Ty virus-like particles elicits HIV-1 p24-specific cellular and humoral immune responses
25. Protein particle vaccines against malaria
26. Induction of single and dual cytotoxic T-lymphocyte responses to viral proteins in mice using recombinant hybrid Ty-virus-like particles